AZGP1 and posterior cortical atrophy: Notably, the comparison in AZGP1 in the unbound fraction was nearly significant (p = 0.06) and demonstrated a similar trend of increased levels in PCa patients, suggesting that AZGP1 may be over-expressed at the protein level and not necessarily displaying differential glycosylation.